Course Description
Target Audience
This educational activity is specifically
designed for medical oncologists,
dermatologists, and other physicians,
physicians-in-training, and healthcare
professionals interested in and/or
involved in the care of patients
with melanoma and its consequences.
Educational Objectives
After successful completion of this
activity, participants should be
able to:
- Describe the basic concepts of immunotherapy and how each type can be used as a treatment modality in oncology.
- Discuss the role immune tolerance plays in allowing the growth and spread of cancer cells.
- Explain the specific role of CTLA-4 in maintaining immune tolerance and how inhibiting its function can be used in the treatment of malignant melanoma.
- Compare and contrast emerging biological agents, primarily vaccines and cytokines, that are used to stimulate and target a patient’s own immune response against a tumor and are currently in trials for use against melanoma.
Physicians:
Imedex®, LLC is accredited
by the Accreditation Council for
Continuing Medical Education to provide
continuing medical education for
physicians.
Imedex designates this educational
activity for a maximum 2 AMA
PRA Category 1 CreditsTM.
Physicians should only claim credit
commensurate with the extent of their
participation in the activity.
Credits will be awarded upon completion and submission of the self-assessment questions, evaluation form, and CME credit request form to:
Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Fax: +1(770) 751 7334
Deadline for CME Credit submission: Sept 30, 2008
Unapproved and Investigational Uses of Drugs and Devices
This Web cast may contain information about experimental and other uses of drugs or devices that are not currently approved by the Food and Drug Administration (FDA) and/or other national regulatory agencies in the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in this program before use. Participants from other countries should consult with their respective regulatory authorities.
The opinions expressed in this Web cast are the opinions of the authors and do not necessarily reflect the opinions of Imedex or Bristol-Myers Squibb Company.
Corporate Support
This Web cast is supported by an unrestricted educational grant from Bristol-Myers Squibb Company.
Event Organizer
Imedex
4325 Alexander Drive
Alpharetta, GA 30022
Tel.: +1 (770) 751 7332
Fax: +1(770) 751 7334
Disclosure of Financial Interests
As an accredited provider
of continuing medical education,
Imedex is required to ask speakers
to disclose any real or apparent
conflict of interest they may have
as related to the contents of their
presentation(s). The existence of
commercial or financial interests
of speakers related to the subject
matter of their presentation(s) should
not be construed as implying bias
or decreasing the value of their
presentation(s). However, disclosure
should help participants form their
own judgments.
All speakers were independently selected by the organizing committee. Those speakers who disclosed affiliations or financial interests with the commercial organizations involved with products, to which they may refer, are listed below.
1=grant/research support 2=consultant 3=speaker’s bureau 4=stock shareholder 5=other support
F. Stephen Hodi Jr, MD -
Amgen1, Bayer Pharmaceuticals
Corporation1, Novartis
Pharmaceuticals Corporation1,2,
Onyx Pharmaceuticals, Inc.1,
Pfizer Inc 1,2, Synta
Pharmaceuticals2
Vernon K. Sondak, MD - Schering Oncology/Biotech3
Jedd D. Wolchok, MD, PhD -
Pfizer Inc2
The following speakers have reported an affiliation with the supporters of this conference:
F. Stephen Hodi Jr, MD - Bristol-Myers Squibb Company1,2
Jedd D. Wolchok, MD, PhD - Bristol-Myers Squibb Company2
Imedex Staff Disclosure
of Financial Relationships
All Imedex staff members who are in a position to control the content of this activity have no financial relationships with any commercial interests that are relevant to this activity.
Imedex is an independent provider
of continuing medical education.
Imedex has no proprietary or financial
interest in medical or healthcare
products over which the FDA has regulatory
authority.
Imedex
is solely
responsible for
this program’s
content. Although
Imedex attempts
to ensure
that the
information in
our programs
is accurate
and timely,
matters and
opinions discussed
and/or presented
with respect
to clinical
matters are
those of
the discussion
participants only,
and not
necessarily those
of Imedex.
Moreover, although
Imedex attempts
to identify
and integrate
the most
qualified medical
professionals in
our program,
TO THE
FULLEST EXTENT
PERMITTED BY
LAW, IMEDEX
EXPRESSLY DISCLAIM
ALL WARRANTIES,
EITHER EXPRESS
OR IMPLIED,
STATUTORY OR
OTHERWISE, INCLUDING
BUT NOT
LIMITED TO
THE IMPLIED
WARRANTIES OF
MERCHANTABILITY, NON-INFRINGEMENT
OF THIRD
PARTIES’ RIGHTS,
AND FITNESS
FOR A
PARTICULAR PURPOSE,
WITH RESPECT
TO THE
CONTENT PRESENTED.
IMEDEX FURTHER
MAKES NO
REPRESENTATIONS OR
WARRANTIES ABOUT
THE ACCURACY,
RELIABILITY, COMPLETENESS
OR TIMELINESS
OF THE
CONTENT OR
ANY MATERIAL
PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2007
Imedex,
LLC.
All
rights
reserved.
Reproduction
in
whole
or
part
is
prohibited
without
prior
written
consent
from
Imedex
and
contributing
faculty.
Systems Requirements
- Pentium 500 processor or greater
- Windows 98/NT/2000/XP or Mac OS 9/X
- Microsoft Internet Explorer 5.5 or later
- Windows Media Player 9.0 or later
- 128 MB of RAM
- Monitor settings: High color at 800 x 600 pixels
- Sound card and speakers
- Abstracts require Adobe Acrobat Reader
Audio troubleshooting
For general troubleshooting concerning audio or video playback issues consult the following web link: http://support.microsoft.com/kb/306317.
For questions or comments regarding the content or performance of this webcast please contact Imedex at meetings@imedex.com. |
